Diabetes companies are expected to continue to invest in building their diabetes enterprises as the incidence of diabetes around the world explodes. The types of companies expected to benefit from the growth in diabetes include drug companies as well as glucose monitoring and insulin delivery device companies. These companies must work with all of the stakeholders and partners in the diabetes community to deliver effective treatments, technologies and services to the global community of citizens whose lives are being impacted by diabetes. These companies must partner with academic researchers, clinicians, health care practitioners, heathcare advocates, and patients, to name a few, to bring better health outcomes to those affected by diabetes.
Blood glucose meters continue to improve rapidly in their accuracy and their response time. Today, the administering of a glucose blood test takes less than a minute and the finger stick is much less painful with the current devices avalable on the market. Meter companies include the following:
The number of insulin pump users has grown rapidly and is expected to continue to grow as more diabetics become aware of the benefits of using the pump such as tighter control and greater convenience. One of the big challenges that remain is to be able to offer a pump solution that can be made affordable to the vast majority of the target diabetic population who cannot afford the pump today. Pump companies include the following:
As the incidence of diabetes explodes globally more drug companies are turning their attention to boosting their efforts in this market. Top players include: